(Reuters) – Jordan’s Hikma Pharmaceuticals said on Wednesday it was entering the Ethiopian market through a joint venture with Sheikh Mohammed Hussein Al Amoudi’s MIDROC Group.
London-listed Hikma said the joint venture, named HikmaCure, would establish an Ethiopian operating company, build a local manufacturing facility and would begin marketing and distributing pharmaceutical products in Ethiopia.
The two groups will provide up to $22.3 million each to the joint venture, Hikma said in a statement.
Source: Reuters.com
Related articles on the web
German pharmaceutical company opens office in Ethiopia
Ethiopia: London based Hikma Pharmaceuticals signs joint venture with MIDROC to enter Ethiopian medicine market
Researchers at the University of Gondar found that Honey and Ginger Kill Superbugs Better than Pharmaceutical Meds
The First Commercial Food Laboratory to be Operational Soon
Ethiopia earns $456 million from gold exports
Bottled water producing companies got five months limitation for product standardization
Government drops plans to make homosexuality non-pardonable offence
England : Alcoholic drinks should carry health warnings, says parliamentary group
Ethiopia’s pharmaceutical industry struggles to meet local demand
Joke – The Proposal – Local man Kebede Proposes to Alamz
University of Gondor constructing referral hospital
Ebola puts focus on drugs made in tobacco plants
Join Conversations